期刊
CURRENT OPINION IN PULMONARY MEDICINE
卷 27, 期 3, 页码 210-215出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MCP.0000000000000760
关键词
macrolides; pneumonia; sepsis; severe community-acquired pneumonia
This article highlights recent advances in treatment guidelines for patients with sCAP, emphasizing important points in the diagnosis and treatment of sCAP, as well as the challenges in management and the need for clearer recommendations.
Purpose of review We highlight the recent advances in the guidelines for treating patients with severe community-acquired pneumonia (sCAP). Recent findings sCAP is a significant cause of hospital admissions. We performed an extensive review of the literature, covering studies from the last several years, to summarise the most important points in the diagnosis and treatment of patients hospitalised with sCAP. sCAP is associated with a high clinical burden. Therefore, deep knowledge is necessary for its management. In general, diagnosis, treatment and management are based on many published guidelines. However, the mortality rate is still unacceptably high, indicating the need for clear recommendations in the management of patients with sCAP. The choice of empirical antibiotic therapy for sCAP depends on multiple factors, such as national and local antimicrobial susceptibility data and the characteristics of the patients, including their risk factors for acquiring infections caused by multidrug-resistant pathogens. Currently, there are several published international guidelines. The aim of this review is to explore the areas that require further knowledge and new recommendations for current clinical practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据